Sorry - There were no pages found that contain that search phrase.
 |
|
|
|
|
|
Treatment |
|
Location |
|
Last Updated |
|
|
|
Details |
|
A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma
|
|
New York, NY USA |
|
07/24/2008 |
|
|
|
|
|
Details |
|
A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Cancer |
|
New York, NY USA |
|
07/24/2008 |
|
|
|
Details |
|
Effect of NovoTTF-100A in Recurrent GBM |
|
Manhasset, NY USA |
|
07/23/2008 |
|
|
|
|
|
Details |
|
Effect of NovoTTF-100A in Recurrent GBM |
|
New York, NY USA |
|
07/23/2008 |
|
|
|
Details |
|
Effect of NovoTTF-100A in Recurrent GBM |
|
NEW YORK CITY, NY USA |
|
07/23/2008 |
|
|
|
|
|
Details |
|
Effect of NovoTTF-100A in Recurrent GBM |
|
New York, NY USA |
|
07/23/2008 |
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Syracuse, NY USA |
|
07/03/2008 |
|
|
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Buffalo, NY USA |
|
07/03/2008 |
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
New York, NY USA |
|
07/03/2008 |
|
|
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
New York, NY USA |
|
07/03/2008 |
|
|
|
Details |
|
Phase 2, 2-Part, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of CT-322 Monotherapy and Combination Therapy With Irinotecan in Patients With Recurrent Glioblastoma Multiforme |
|
New York, NY USA |
|
04/27/2008 |
|
|
|
|
|
Details |
|
Phase I and II, Open-Label, Multi-Center Trials of Pazopanib in Combination with Lapatinib in Adult Patients with Relapsed Malignant Glioma |
|
New York, NY USA |
|
04/15/2008 |
|
|
|
Details |
|
Phase I/II Studies of BAY 43-9006 (Sorafenib) in Combination With OSI-774 (Erlotinib), R115777 (Tipifarnib) or CCI-779 (Temsirolimus) in Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma |
|
New York, NY USA |
|
04/15/2008 |
|
|
|
|
|
Details |
|
Phase II Single Arm Trial of VEGF Trap in Patients With Recurrent Temozolomide-Resistant Malignant Gliomas |
|
New York, NY USA |
|
04/15/2008 |
|
|
|
Details |
|
A Phase I Study of Vorinostat [Suberoylanilide Hydroxamic Acid (SAHA)] in Combination with Temozolomide in Patients with Malignant Gliomas |
|
New York, NY USA |
|
04/15/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Syracuse, NY USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Rochester, NY USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme |
|
New York, NY USA |
|
04/11/2008 |
|
|
|
Details |
|
NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 |
|
Buffalo, NY USA |
|
03/01/2008 |
|
|
|
|
|
Details |
|
Gliogene: Brain Tumor Linkage Study |
|
New York, NY USA |
|
01/17/2008 |
|
|
|
Details |
|
High dose erlotinib for recurrent/residual GBM; Correlation of response to EGFRvIII and PTEN status |
|
New York, NY USA |
|
11/08/2007 |
|
|
|
|
|
Details |
|
NABTC 04-01: Lapatinib in Treating Patients Who Are Undergoing Surgery for Recurrent Progressive Glioblastoma Multiforme or Gliosarcoma |
|
New York, NY USA |
|
10/03/2007 |
|
|
|
Details |
|
NABTC 04-02: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
|
|
New York, NY USA |
|
10/03/2007 |
|
|
|
|
|
Details |
|
A Pharmacokinetic and Phase 2 Study of Sunitinib Malate in Recurrent Malignant Gliomas |
|
New York, NY USA |
|
08/26/2007 |
|
|
|
Details |
|
Phase II Study of Intrathecal I-3F8 in Patients With GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms |
|
New York, NY USA |
|
08/20/2007 |
|
|
|
|
|
Details |
|
A Phase 1/11 Study of Topotecan by Intracerebral Clysis for the Treatment of Recurrent Primary Malignant Brain Tumors |
|
NEW YORK CITY, NY USA |
|
08/20/2007 |
|
|
|
Details |
|
Phase I/II Study of ZD6474 (ZactimaTM) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma |
|
New York, NY USA |
|
08/19/2007 |
|
|
|
|
|
Details |
|
A Phase II Trial of Continuous Low-Dose Temozolomide for Patients With Recurrent Malignant Glioma |
|
New York, NY USA |
|
08/18/2007 |
|
|
|
Details |
|
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
|
New York, NY USA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Functional image guided removal of brain tumors |
|
Manhasset, NY USA |
|
08/18/2007 |
|
|
|
Details |
|
Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma |
|
New York, NY USA |
|
08/04/2007 |
|
|
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Buffalo, NY USA |
|
05/01/2007 |
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Utica, NY USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
|
Manhasset, NY USA |
|
05/01/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Brooklyn, NY USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Rochester, NY USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
New York, NY USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Valhalla, NY USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
New Hyde Park, NY USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Clinical and Molecular-Metabolic Trial of Perifosine for Recurrent/Progressive Malignant Gliomas |
|
New York, NY USA |
|
04/15/2007 |
|
|
|
Details |
|
Phase I/II Trial of Oral Erlotinib (Tarceva, OSI-774) for Treatment of Relapsed/Refractory Glioblastoma Multiforme and Anaplastic Astrocytoma
|
|
New York, NY USA |
|
10/12/2006 |
|
|
|
|
|
Details |
|
TREATMENT OF NEWLY DIAGNOSED, HIGH-GRADE, MALIGNANT GLIOMA WITH POLIFEPROSAN 20 CONTAINING CARMUSTINE IMPLANT (GLIADEL® WAFER) USING MR SPECTROSCOPY DATA AS A PRIMARY INDICATOR OF THERAPEUTIC RESPONSE |
|
New York, NY USA |
|
10/12/2006 |
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Brooklyn, NY USA |
|
10/12/2006 |
|
|
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Brooklyn, NY USA |
|
10/12/2006 |
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Albany, NY USA |
|
10/12/2006 |
|
|
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Brooklyn, NY USA |
|
10/12/2006 |
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
New York, NY USA |
|
10/12/2006 |
|
|
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Stony Brook, NY USA |
|
10/12/2006 |
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
New Hyde Park, NY USA |
|
10/12/2006 |
|
|
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Brooklyn, NY USA |
|
10/12/2006 |
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Syracuse, NY USA |
|
10/12/2006 |
|
|
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Bronx, NY USA |
|
10/12/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
New York, NY USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Valhalla, NY USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Syracuse, NY USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase II Study of Rituximab, Temozolomide, and Methylprednisolone in Patients With Recurrent Primary CNS Non-Hodgkin`s Lymphoma |
|
New York, NY USA |
|
05/27/2006 |
|
|
|
Details |
|
PEG-Interferon alfa-2b With or Without Thalidomide in Treating Patients With Recurrent High-Grade Gliomas
|
|
New York, NY USA |
|
05/04/2006 |
|
|
|
|
|
Details |
|
A Phase I/II Trial of PEG-Interferon Alfa-2B (PEG-Intron)
for Plexiform Neurofibromas (NF1 patients) |
|
New York, NY USA |
|
12/04/2005 |
|
|
|
Details |
|
Fractionated Stereotactic Radiosurgery plus Topotecan radiation sensitizer in the treatment of recurrent malignant astrocytoma or as consolidation after external beam radiotherapy. |
|
New York, NY USA |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Gliadel Wafer Implantation For Malignant Gliomas Of The Brain |
|
Smithtown, NY USA |
|
12/03/2005 |
|
|
|
Details |
|
Gamma Knife Radiosurgery |
|
Smithtown, NY USA |
|
12/03/2005 |
|
|
|
|
|
Details |
|
A Phase I dose escalation trial of Temodar that will attempt to determine the maximum tolerated dose of Temodar (Temozolomide) when given by prolonged oral exposure to children with recurrent or progressive brain tumors. |
|
New York, NY USA |
|
12/03/2005 |
|
|
|
Details |
|
Fractionated Streotactic Rdaiotherapy boost and Temozolamide in malignant Gliomas |
|
Brooklyn, NY USA |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Gamma knife stereotactic radiosurgery for benign and malignant brain tumors and brain metastases. |
|
Rockville Centre, NY USA |
|
12/03/2005 |
|
|
|
Details |
|
Fractionated stereotactic radiotherapy for the treatment of acoustic neuromas, meningiomas and metastatic brain tumors. |
|
New York, NY USA |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Phosphorus 32 in Treating Patients With Glioblastoma Multiforme
|
|
Garden City, NY USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Brooklyn, NY USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Brooklyn, NY USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Albany, NY USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Brooklyn, NY USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
New York, NY USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Rochester, NY USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Stony Brook, NY USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
New York, NY USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
New York, NY USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Valhalla, NY USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
New York, NY USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
New Hyde Park, NY USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Brooklyn, NY USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Syracuse, NY USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Bronx, NY USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
A Randomized Phase II Study of Peg-Interferon Alpha-2B (Peg-Intron) Alone or in Combination with Thalidomide in Adults with Recurrent High-Grade Gliomas |
|
New York, NY USA |
|
11/27/2005 |
|
|
|
Details |
|
Regulus Navigator for use with a three point pinion - frameless stereotactic surgery |
|
New York, NY USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Volumetric Stereotactic Procedures |
|
New York, NY USA |
|
11/27/2005 |
|
|
|
Details |
|
Frameless Computer Guided Stereotactic Surgery For Brain Tumors |
|
New York, NY USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer |
|
New York, NY USA |
|
11/27/2005 |
|
|
|
Details |
|
Computer assisted minimally invasive image guided surgery for improved resection of malignant brain tumors and frameless stereotactic brain biopsies For Deep Brain Tumors. |
|
Smithtown, NY USA |
|
11/26/2005 |
|
|
|
|
|
Details |
|
A Phase II Trial of Cisplatinum and Temodar followed by Cranial Irradiation and Temodar in Adults with Newly Diagnosed Glioblastoma Multiforme |
|
Rochester, NY USA |
|
11/26/2005 |
|
|
|
Details |
|
Headstart II A Phase II study of two alternative intensive induction chemotherapy followed by consolidation with myeloablative chemotherapy and autologous stem cell rescue with or without
subsequent radiation therapy for children less than 10 yrs of age newly diagnosed with malignant brain tumors |
|
New York, NY USA |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors
|
|
New York, NY USA |
|
11/26/2005 |
|
|
|
Details |
|
Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors
|
|
New York, NY USA |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors
|
|
New York, NY USA |
|
11/26/2005 |
|
|
|
Details |
|
Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors
|
|
Valhalla, NY USA |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors
|
|
Syracuse, NY USA |
|
11/26/2005 |
|
|
|
Details |
|
Phase II Treatment of Patients with Progressive Low Grade Gliomas with Temodal |
|
New York, NY USA |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Phase I trial to study the effectiveness of combining paclitaxel with radiation therapy in treating children who have newly diagnosed brain stem glioma. |
|
New York, NY USA |
|
11/26/2005 |
|
|
|
Details |
|
Concurrent Temozolomide and Radiotherapy Followed By Dose Dense Versus Metronomic Temozolomide and Maintenance Cis-Retinoic Acid For Patients With Newly Diagnosed Glioblastoma And Other Malignant Gliomas |
|
New York, NY USA |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Phase I/II Trial of Temodar and Escalating Doses of Oral VP-16 for Patients with Recurrent Malignant Glioma |
|
Rochester, NY |
